Coelen Robert J S, Ruys Anthony T, Besselink Marc G H, Busch Olivier R C, van Gulik Thomas M
Department of Surgery, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Surg Endosc. 2016 Oct;30(10):4163-73. doi: 10.1007/s00464-016-4788-y. Epub 2016 Feb 19.
Despite extensive preoperative staging, still almost half of patients with potentially resectable perihilar cholangiocarcinoma (PHC) have locally advanced or metastasized disease upon exploratory laparotomy. The value of routine staging laparoscopy (SL) in these patients remains unclear with varying results reported in the literature. The aim of the present systematic review was to provide an overview of studies on SL in PHC and to define its current role in preoperative staging.
A systematic review and meta-analysis were performed in PubMed and EMBASE regarding studies providing data on the diagnostic accuracy of SL in PHC. Primary outcome measures were the overall yield and sensitivity to detect unresectable disease. Secondary outcomes were the yield and sensitivity for recent studies (after 2010) and large study cohorts (≥100 patients) and specific (metastatic) lesions. Methodological quality of studies was assessed with the Quality Assessment of Diagnostic Accuracy Studies tool.
From 173 records, 12 studies including 832 patients met the inclusion criteria. The yield of SL in PHC varied from 6.4 to 45.0 % with a pooled yield of 24.4 % [95 % confidence interval (CI) 16.4-33.4]. Sensitivity to detect unresectable disease ranged from 31.6 to 75 % with a pooled sensitivity of 52.2 % (95 % CI 47.1-57.2). Sensitivity was highest for peritoneal metastases (80.7 %, 95 % CI 70.9-88.3). Subgroup analysis revealed that the yield and sensitivity tended to be lower for studies after 2010. Considerable heterogeneity was detected among the studies.
The results of the pooled analyses suggest that one in four patients with potentially resectable PHC benefits from SL. Given considerable heterogeneity, a trend to lower yield in more recent studies and further improvement of preoperative imaging over time, the routine use of SL seems discouraging. Studies that identify predictors of unresectability, that enable selection of patients who will benefit the most from this procedure, are needed.
尽管进行了广泛的术前分期,但在接受探查性剖腹手术时,仍有近一半的潜在可切除性肝门部胆管癌(PHC)患者存在局部进展或转移性疾病。常规分期腹腔镜检查(SL)在这些患者中的价值仍不明确,文献报道的结果各异。本系统评价的目的是概述关于PHC中SL的研究,并确定其在术前分期中的当前作用。
在PubMed和EMBASE中进行了一项系统评价和荟萃分析,纳入提供PHC中SL诊断准确性数据的研究。主要结局指标是检测不可切除疾病的总体检出率和敏感性。次要结局是近期研究(2010年后)和大型研究队列(≥100例患者)以及特定(转移性)病变的检出率和敏感性。使用诊断准确性研究质量评估工具评估研究的方法学质量。
从173条记录中,12项研究(包括832例患者)符合纳入标准。PHC中SL的检出率在6.4%至45.0%之间,汇总检出率为24.4%[95%置信区间(CI)16.4 - 33.4]。检测不可切除疾病的敏感性在31.6%至75%之间,汇总敏感性为52.2%(95%CI 47.1 - 57.2)。腹膜转移的敏感性最高(80.7%,95%CI 70.9 - 88.3)。亚组分析显示,2010年后的研究中检出率和敏感性往往较低。研究间存在相当大的异质性。
汇总分析结果表明,四分之一的潜在可切除性PHC患者可从SL中获益。鉴于存在相当大的异质性、近期研究中检出率有下降趋势以及随着时间推移术前影像学的进一步改善,常规使用SL似乎并不乐观。需要开展研究来确定不可切除性的预测因素,以便能够选择从该手术中获益最大的患者。